Home > Animal Health & Nutrition > Veterinary Services > Veterinary Pharmacovigilance Market

Veterinary Pharmacovigilance Market Trends

  • Report ID: GMI10276
  • Published Date: Jul 2024
  • Report Format: PDF

Veterinary Pharmacovigilance Market Trends

The growing adoption of companion and livestock animals is significantly driving the growth of the market. For instance, as per the report published by Global Animal Health Association, families in the U.S., Brazil, EU, and China alone account for over half a billion dogs and cats, while more than half the world is estimated to have a pet at home. Similalrly, in the U.S., 70 percent of households owned a pet as of 2021 compared to 68 percent in 2016. Thus, the growing trend of pet humanization, where pets are treated as family members, leads to higher expenditure on pet healthcare, including the safety monitoring of veterinary drugs. This has increased the demand for veterinary pharmacovigilance services that is anticipated to propel the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The veterinary pharmacovigilance market was valued at USD 814.4 million in 2023 and will grow at 12.7% CAGR during 2024-2032 owing to the rising occurrence of various animal diseases.

The companion animals segment in the market held 64.1% share in 2023 due to the continuous advancements in veterinary medicine.

North America veterinary pharmacovigilance market secured 46.2% share in 2023 attributed to the rise in pet ownership.

Accenture, ArisGlobal, Azierta Contract Science Support Consulting, Biologit, Covetrus, Inc., Ennov, Indivitrus, Knoell, Leon Research, and Medfiles among others.

Veterinary Pharmacovigilance Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 337
  • Countries covered: 22
  • Pages: 208
 Download Free Sample